Mobia Medical, Inc.
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
(a) On November 2, 2026, the Compensation Committee approved and adopted the Mobia Medical, Inc. Annual Incentive Plan (the “AIP”) under the 2026 Incentive Award Plan. The AIP provides annual bonus opportunities for eligible U.S.-based employees, including eligible executive officers, based on corporate performance and, where applicable, individual performance. Target awards are based on a percentage of eligible salary or wages, with targets, performance goals and weightings determined by the plan administrator. Awards may be paid in cash, common stock, stock options or other equity-based awards, or a combination thereof, subject to the AIP’s terms and conditions.
(b) None.
(c) During the three months ended September 30, 2026, noneof our officers or directors (as defined in Rule 16a-1 under the Exchange Act) adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” (as those terms are defined in Item 408 of Regulation S-K).
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.